Skip to main content
Hanmi Science Co.,Ltd logo

Hanmi Science Co.,Ltd — Investor Relations & Filings

Ticker · 008930 ISIN · KR7008930000 KO Manufacturing
Open in API
Filings indexed 698 across all filing types
Latest filing 2025-06-13 Major Shareholding Noti…
Country KR South Korea
Listing KO 008930

About Hanmi Science Co.,Ltd

https://www.hanmipharm.com/

Hanmi Science Co., Ltd. is a holding company that manages subsidiaries engaged in the pharmaceutical and healthcare sectors. Its principal operating subsidiary, Hanmi Pharmaceutical, is an R&D-centric biopharmaceutical company focused on the development of innovative new drugs. The group's integrated activities span from in-house research and development to the manufacturing and commercialization of a wide range of pharmaceutical products. A key strategic focus is the creation of novel therapies to address unmet medical needs, which are then provided to medical professionals.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and contractual relationships (such as collateral and stock lending) of major shareholders and their special related parties. This type of document is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-06-13 Korean
기업지배구조보고서공시
Governance Information Classification · 100% confidence The document is a 'Corporate Governance Report' (기업지배구조보고서) for Hanmi Science Co., Ltd. It details the company's governance structure, shareholder rights, board composition, and compliance with governance indicators. This type of report is a standard regulatory filing in South Korea, specifically categorized under Corporate Governance Reports (CGR).
2025-06-02 Korean
투자판단관련주요경영사항(자회사의 주요경영사항)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Hanmi Science regarding a 'major management matter' (투자판단 관련 주요경영사항), specifically the approval of a new drug (Amoprel) by the Ministry of Food and Drug Safety. It details clinical trial results, regulatory approval status, and future market plans. Since this is a specific regulatory disclosure of a material event that does not fit into categories like financial reports, dividends, or M&A, it is classified as a general Regulatory Filing (RNS).
2025-05-30 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a '최대주주등소유주식변동신고서' (Report of Change in Shareholding by Major Shareholders and Related Parties) filed by Hanmi Science. It details specific share transactions (buy/sell) by company executives and major shareholders, including the date of change, the number of shares, and the resulting ownership percentage. This falls under the category of Director's Dealing (DIRS) as it reports insider share transactions.
2025-05-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This is a standard regulatory filing in South Korea used to disclose insider trading or changes in share ownership by company directors and executives. Based on the provided categories, this aligns with 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2025-05-29 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Hanmi Science. It details specific share transactions (a sale of 3,000 shares by an individual named Lim Jong-min) and provides a comprehensive table of the current shareholding status of all major shareholders. This type of filing is a standard regulatory disclosure in South Korea regarding changes in ownership by insiders or major shareholders, which falls under the 'Major Shareholding Notification' category.
2025-05-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.